Adrenergic agonist Drugs Flashcards
1
Q
isoproterenol
A
- nonselective β adrenergic agonist.
- increases cardiac contractility (positive inotropic effect) by acting on myocardial β-1 adrenergic receptors.
- also binds to β-2 adrenergic receptors and causes vasodilation by relaxation of vascular smooth muscle, leading to decreased vascular resistance and mean arterial blood pressure.
negligible effects on α-1 adrenergic receptors. - increases the cardiac rate and output as well as the pulse pressure.
2
Q
Adenosine
A
- acts on A1 receptors on cardiac cells and activates potassium channels
- increasing potassium conductance
- leads to transient conduction delay through
the atrioventricular node. - can also cause peripheral vasodilation, but it attenuates the adrenergic-mediated increase in myocardial contractility.
3
Q
Phenylephrine
A
- selective alpha-1 adrenergic receptor agonist that causes marked arterial vasoconstriction when administered intravenously.
- increase in systemic vascular resistance and blood pressure.
- induced blood pressure increase elicits a baroreceptor-mediated increase in vagal tone, which results in decreased stroke volume and a slowed heart rate
- pulse pressure, defined as the systolic pressure minus the diastolic pressure, is decreased by phenylephrine because of the reflex decrease in stroke volume and the increased afterload.
- sympathomimetic drug with pure α adrenergic agonist activity.
- causes vasoconstriction with an increase in systemic vascular resistance.
4
Q
Dobutamine
A
complex adrenergic agonist whose physiologic effects are primarily the result of beta-adrenergic receptor agonism
- increases the heart’s rate and contractility while exerting little effect on peripheral vascular resistance.
5
Q
Epinephrine endogenous catecholamine that stimulates both alpha- and beta-adrenergic receptors
A
endogenous catecholamine that stimulates both alpha- and beta-adrenergic receptors
- Infused intravenously, epinephrine increases the pulse rate and pulse pressure and decreases the peripheral vascular resistance.
- The latter finding is due to the dominant effect of epinephrine on beta-2 adrenergic receptors compared to its effect on alpha-1 receptors.
6
Q
Norepinephrine
A
acts on α-1 receptors, causing vasoconstriction and an increase in systemic vascular resistance.
- acts as a weak agonist at β-1 receptors, with a modest increase in myocardial contractility.